Tsumura & Co
4540.TPharmaceutical
Filed as TSUMURA & CO. (2022-06–2026-06)
Financials · Standalone
| Fiscal year ended | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|---|
| Revenue | ¥160.6bn | ¥159.8bn | ¥131.3bn | ¥123.8bn | ¥118.5bn | ¥109.0bn |
| Operating income | ¥28.3bn | ¥32.6bn | ¥16.5bn | ¥19.5bn | ¥20.4bn | ¥19.2bn |
| Ordinary income | ¥32.8bn | ¥32.8bn | ¥18.4bn | ¥20.2bn | ¥21.1bn | ¥19.8bn |
| Total assets | ¥430.3bn | ¥360.0bn | ¥350.2bn | ¥333.9bn | ¥296.8bn | ¥283.9bn |
| Net assets / equity | ¥265.8bn | ¥251.2bn | ¥238.5bn | ¥226.6bn | ¥218.6bn | ¥208.6bn |
| EPS (basic) | ¥326.55 | ¥341.95 | ¥180.59 | ¥195.46 | ¥196.39 | ¥180.12 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 13
| Period | Form | Figures |
|---|---|---|
| 2025-04-01 → 2026-03-31 | Annual | 197 figures · EDINET |
| 2025-04-01 → 2025-09-30 | Half-year | 67 figures · EDINET |
| 2024-04-01 → 2025-03-31 | Annual | 197 figures · EDINET |
| 2024-04-01 → 2024-09-30 | Half-year | 67 figures · EDINET |
| 2023-04-01 → 2024-03-31 | Annual | 197 figures · EDINET |
| 2023-04-01 → 2023-12-31 | Quarterly Q3 | 69 figures · EDINET |
| 2023-04-01 → 2023-09-30 | Quarterly Q2 | 69 figures · EDINET |
| 2023-04-01 → 2023-06-30 | Quarterly Q1 | 67 figures · EDINET |
| 2022-04-01 → 2023-03-31 | Annual | 197 figures · EDINET |
| 2022-04-01 → 2022-12-31 | Quarterly Q3 | 69 figures · EDINET |
| 2022-04-01 → 2022-09-30 | Quarterly Q2 | 69 figures · EDINET |
| 2022-04-01 → 2022-06-30 | Quarterly Q1 | 67 figures · EDINET |
| 2021-04-01 → 2022-03-31 | Annual | 197 figures · EDINET |
21 more reports are still being processed.